Datavant Acquires Aetion

July 13, 2025

Datavant has completed its acquisition of Aetion, bringing the real-world evidence (RWE) platform into Datavant’s Life Sciences business to create an end-to-end data feasibility and analysis offering. The deal combines Datavant’s data connectivity network with Aetion’s RWE analytics to expand capabilities for biopharma, device makers, payers, and regulators.

Buyers
Datavant
Targets
Aetion
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.